Microbial Fermentation Technology - Global Strategic Business Report: Secure Share of the $45.2B Market by 2030 as Lonza, Roche, Novozymes and Biocon Accelerate Scale

Boost ROI with engineered strains, automated bioreactors and continuous processing to raise yields, cut costs and unlock sustainable bioproduct opportunities.

Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Microbial Fermentation Technology - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Microbial Fermentation Technology Market to Reach US$45.2 Billion by 2030

The global microbial fermentation technology market was valued at US$33.2 billion in 2024 and is projected to reach US$45.2 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.3%. Market growth is supported by rising demand for sustainable manufacturing, increased production of biologics and biosimilars, and continued advances in synthetic biology, genetic Engineering , and bioprocess optimization.

The comprehensive microbial fermentation technology market report examines industry trends, growth drivers, competitive dynamics, regional opportunities, and forecasts through 2030. It also incorporates the latest global tariff developments, trade negotiations, supply chain disruptions, sourcing changes, and geographic realignment affecting microbial fermentation companies and their customers.

Market Trends and Technology Developments

Technological innovation is improving the efficiency, scalability, and commercial potential of microbial fermentation. Genetic Engineering and synthetic biology are enabling the development of microbial strains with higher yields, faster production cycles, and the ability to synthesize novel compounds. These capabilities are expanding fermentation applications in pharmaceuticals, industrial biotechnology, food production, agriculture, specialty chemicals, and renewable energy.

Advanced bioreactors are also strengthening market growth. Automated systems can precisely control temperature, pH, oxygen, and nutrient supply, improving process consistency and productivity. Continuous-flow bioreactors, cell-free production systems, and flexible fermentation platforms can reduce downtime while supporting scalable manufacturing across multiple microbial cultures and product categories.

Genomics, metabolomics, proteomics, bioinformatics, and CRISPR-based gene editing are accelerating strain development and process optimization. These technologies support more efficient substrate conversion, improved biosynthetic pathway identification, lower production costs, and faster commercialization of fermentation-derived products.

Expanding Applications Across Major Industries

Pharmaceutical and biopharmaceutical manufacturers use microbial fermentation to produce antibiotics, vaccines, insulin, recombinant proteins, and other therapeutic products. Growing demand for biologics and biosimilars is encouraging investment in scalable fermentation capacity among biopharmaceutical companies, contract development and manufacturing organizations, and research institutions.

Food and beverage applications include amino acids, vitamins, organic acids, enzymes, probiotics, and ingredients that improve nutrition, flavor, texture, and shelf life. Fermentation also supports innovation in functional foods and plant-based alternatives by enabling the production of proteins and flavor compounds with targeted performance characteristics.

In energy and agriculture, microbial fermentation supports the production of bioethanol, biobutanol, biopesticides, biofertilizers, and animal feed additives. The use of renewable feedstocks and agricultural residues can reduce dependence on Fossil resources while supporting lower-emission manufacturing and circular economy strategies.

Key Growth Drivers

  • Increasing demand for sustainable and renewable production processes.
  • Rising adoption of biologics, biosimilars, vaccines, and therapeutic proteins.
  • Advances in genetic Engineering , synthetic biology, and metabolic pathway optimization.
  • Greater investment in automated bioreactors and scalable biomanufacturing facilities.
  • Expanding use of fermentation-derived ingredients in food, agriculture, energy, and specialty chemicals.
  • Government and industry initiatives focused on reducing emissions and strengthening supply chain resilience.

Market Segment and Regional Highlights

The report analyzes the microbial fermentation technology market by application, including antibiotics, enzymes, recombinant proteins, monoclonal antibodies, small molecules, vaccines, and other applications. End-use coverage includes contract development and manufacturing organizations (CDMOs), biopharmaceutical companies, contract research organizations (CROs), and academic and research institutes.

The antibiotics application segment is forecast to reach US$16.2 billion by 2030, growing at a CAGR of 7.4%. The enzymes segment is projected to expand at a CAGR of 3.4% during the analysis period.

The U.S. microbial fermentation technology market was valued at US$8.9 billion in 2024. China is forecast to grow at a CAGR of 9.2%, reaching US$10.2 billion by 2030. The report also provides market analysis for Canada, Japan, Germany, France, Italy, the United Kingdom, Spain, Russia, India, Australia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, the United Arab Emirates, Israel, Iran, and other markets across Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Tariff, Trade, and Economic Analysis

This edition evaluates tariff negotiations involving more than 180 countries and assesses their potential effects on raw material sourcing, equipment procurement, production costs, supply chains, and manufacturing location decisions. Global and regional forecasts have been revised to reflect economic uncertainty, tariff exposure, and structural changes in international trade. Historical analysis covering 2015 through 2023 provides additional context for long-term market development.

Domain Expert Insights

The report tracks innovation in fermentation processes, emerging biomanufacturing technologies, economic indicators, competitive positioning, and regional investment patterns. Commentary from economists, trade experts, and domain specialists provides context for changing market conditions and helps identify opportunities related to supply chain diversification, capacity expansion, and technology adoption.

Report Benefits

  • Independent annual sales analysis and market forecasts from 2024 to 2030.
  • Detailed coverage of major geographic regions, applications, and end-use sectors.
  • Assessment of market drivers, restraints, risks, and emerging revenue opportunities.
  • Updated 2025 global market share estimates and competitive positioning.
  • Analysis of major participants across strong, active, niche, and limited market positions.
  • Complimentary report updates for one year.

Companies Featured

The report profiles 44 microbial fermentation technology companies. Featured participants include Amyris, Inc.; Biocon Ltd.; BioVectra Inc.; Danone UK; F. Hoffmann-La Roche AG; DSM-Firmenich NV; Lonza AG; Novonesis A/S; TerraVia Holdings, Inc.; and United Breweries Ltd.

By combining market forecasts, competitive intelligence, tariff analysis, technology trends, and regional assessments, the report supports strategic planning for companies seeking opportunities in the global microbial fermentation technology market through 2030.

Key Attributes:

Report Attribute Details
No. of Pages 324
Forecast Period 2024 - 2030
Estimated Market Value (USD) in 2024 $33.2 Billion
Forecasted Market Value (USD) by 2030 $45.2 Billion
Compound Annual Growth Rate 5.3%
Regions Covered Global


For more information about this report visit https://www.researchandmarkets.com/r/wevt3d

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900